Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Robust and stable immediate release formulation of candesartan cilexetil , bcs class iv drug and its statistical optimization

  • In: Dissolution/In Vitro Release Performance Testing- Posters
  • At: Istanbul (Turkey) (2009)
  • Type: Poster
  • Poster code: DIV-P-001
  • By: KOHLI, Kanchan (D/o Pharmaceutics, F/o Pharmacy, Jamia Hamdard University, New Delhi, India)
  • Co-author(s): Kumar, Ramesh (D/o Pharmaceutics, F/o Pharmacy, Jamia Hamdard University, NEW DELHI, India)
    Garg, Abhinav (D/o Pharmaceutics, F/o Pharmacy, Jamia Hamdard University, NEW DELHI, India)
    Kumar, Anoop (D/o Pharmaceutics, F/o Pharmacy, Jamia Hamdard University, NEW DELHI, India)
  • Abstract:

    Candesartan cilexetil (C.C), a selective AT I Antagonist indicated for Hypertension. This potent prodrug poses great challenges to formulators as it falls in Bio classification system (BCS) class IV and hence has a limitation of poor bioavailability and bioequivalence. Present research work aimed at developing a statistically optimized immediate..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses